Martyn Jacobs
Stock Analyst at Bell Potter
(0.07)
# 4,686
Out of 4,969 analysts
206
Total ratings
27.4%
Success rate
-13.8%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: AYA Artrya Limited | Reiterated: Buy | $6.75 → $6.00 | $3.22 | +86.34% | 6 | Sep 10, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.77 → $0.75 | $0.79 | -4.46% | 9 | Aug 31, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Reiterated: Buy | $0.42 | $0.17 | +147.06% | 11 | Aug 31, 2026 | |
| ASX: AHC Austco Healthcare Limited | Reiterated: Buy | $0.45 | $0.27 | +69.81% | 5 | Aug 30, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Reiterated: Buy | $0.25 | $0.10 | +150.00% | 4 | Aug 28, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Reiterated: Buy | $0.75 → $0.50 | $0.17 | +194.12% | 16 | Aug 28, 2026 | |
| ASX: BIO Biome Australia Limited | Reiterated: Buy | $0.75 | $0.36 | +111.27% | 20 | Aug 27, 2026 | |
| ASX: IPD ImpediMed Limited | Reiterated: Buy | $0.01 | $0.01 | +100.00% | 16 | Aug 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.60 → $3.15 | $2.30 | +36.96% | 9 | Aug 26, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Reiterated: Buy | $3.15 | $1.69 | +86.94% | 10 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.00 | $0.50 | +100.00% | 16 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.75 → $27.50 | $19.05 | +44.36% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.90 → $0.70 | $0.26 | +169.23% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.15 | $3.55 | +45.07% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.015 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.054 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.06 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.80 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.115 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.05 | n/a | 7 | Oct 31, 2022 |
Artrya Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $6.75 → $6.00
Current: $3.22
Upside: +86.34%
Monash IVF Group Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $0.77 → $0.75
Current: $0.79
Upside: -4.46%
Oneview Healthcare PLC
Aug 31, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.17
Upside: +147.06%
Austco Healthcare Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $0.45
Current: $0.27
Upside: +69.81%
Lumos Diagnostics Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.10
Upside: +150.00%
Trajan Group Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.75 → $0.50
Current: $0.17
Upside: +194.12%
Biome Australia Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $0.75
Current: $0.36
Upside: +111.27%
ImpediMed Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $0.01
Current: $0.01
Upside: +100.00%
Integral Diagnostics Limited
Aug 26, 2026
Reiterated: Buy
Price Target: $3.60 → $3.15
Current: $2.30
Upside: +36.96%
EMVision Medical Devices Ltd
Aug 25, 2026
Reiterated: Buy
Price Target: $3.15
Current: $1.69
Upside: +86.94%
Aug 24, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.50
Upside: +100.00%
Aug 20, 2026
Reiterated: Buy
Price Target: $28.75 → $27.50
Current: $19.05
Upside: +44.36%
Aug 13, 2026
Reiterated: Buy
Price Target: $0.90 → $0.70
Current: $0.26
Upside: +169.23%
Aug 5, 2026
Reiterated: Buy
Price Target: $5.15
Current: $3.55
Upside: +45.07%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.015
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.054
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.06
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.80
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.115
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.05
Upside: n/a